tradingkey.logo
tradingkey.logo
Search

Movano Inc

MOVE
Add to Watchlist
19.900USD
-1.020-4.88%
Close 05/15, 16:00ETQuotes delayed by 15 min
39.43MMarket Cap
LossP/E TTM

Movano Inc

19.900
-1.020-4.88%
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison
TradingKey Stock Score
Overall Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Peer Comparison

TradingKey Stock Score of Movano Inc

Currency: USD Updated: 2026-05-15

Key Insights

Movano Inc's fundamentals are relatively stable, with an industry-leading ESG disclosure.and its growth potential is good.Its valuation is considered fairly valued, ranking 144 out of 206 in the Healthcare Equipment & Supplies industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 30.00.In the medium term, the stock price is expected to trend up.Despite strong stock market performance and technicals over the past month, the fundamentals don't support the current trend.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.

Movano Inc's Score

Industry at a Glance

Industry Ranking
144 / 206
Overall Ranking
401 / 4482
Industry
Healthcare Equipment & Supplies

Support & Resistance

Relevant data have not been disclosed by the company yet.

Score Analysis

Current score
Previous score

Media Coverage

Last 24 hours
Coverage Level

Very Low
Very High
Negative

Movano Inc Highlights

StrengthsRisks
Movano Inc., doing business as Movano Health, is developing a platform to deliver purpose-driven healthcare solutions to bring medical-grade data to the forefront of consumer health devices. Its commercial product Evie Ring is a wearable designed specifically for women. The Evie Ring combines health and wellness metrics to give a full picture of one’s health, which includes resting heart rate, heart rate variability, blood oxygen saturation, respiration rate, skin temperature variability, period and ovulation tracking, menstrual symptom tracking, activity profile, including steps, active minutes and calories burned, sleep stages and duration, and mood tracking. The Company is also developing a proprietary System-on-a-Chip (SoC) designed for blood pressure or continuous glucose monitoring systems. This data is delivered through a mobile app which simplifies how data is presented and turns biometric data into actionable insights that help women make manageable lifestyle changes.
Growing
The company is in a growing phase, with the latest annual income totaling USD 433.00K.
Undervalued
The company’s latest PE is -1.24, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 108.86K shares, decreasing 47.38% quarter-over-quarter.
Held by Mairs and Power
Star Investor Mairs and Power holds 50.97K shares of this stock.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Financial Health

Currency: USD Updated: 2026-05-15

The current financial score of Movano Inc is 5.19, ranking 202 out of 206 in the Healthcare Equipment & Supplies industry. Its financial status is weak, and its operating efficiency is low. Its latest quarterly revenue reached 44.00K, representing a year-over-year decrease of 60.36%, while its net profit experienced a year-over-year decrease of 27.60%.

Score

Industry at a Glance

Previous score
5.19
Change
0

Financials

5.57

Key Metrics

Cash and cash equivalents
Total assets
Total liabilities
Free cash flow
Relevant data have not been disclosed by the company yet.

Quality of Earnings

6.82

Operational Efficiency

2.84

Growth Potential

3.63

Shareholder Returns

7.08

Movano Inc's Company Valuation

Currency: USD Updated: 2026-05-15

The current valuation score of Movano Inc is 7.49, ranking 79 out of 206 in the Healthcare Equipment & Supplies industry. Its current P/E ratio is -1.24, which is -96.62% below the recent high of -0.04 and -4761.48% above the recent low of -60.28.

Score

Industry at a Glance

Previous score
7.49
Change
0

Valuation Dimensions

P/E
P/B
P/S
P/CF
Industry Ranking 144/206
Relevant data have not been disclosed by the company yet.

Earnings Forecast

Currency: USD Updated: 2026-05-15

No earnings forecast score is currently available for Movano Inc. The Healthcare Equipment & Supplies industry's average is 7.80. The average price target is 30.00, with a high of 30.00 and a low of 30.00.

Score

Industry at a Glance

Previous score
0.00
Change
0

Support & Resistance

Relevant data have not been disclosed by the company yet.

Analyst Rating

Based on 1 analysts
Buy
Current Rating
30.000
Target Price
+4801.96%
Upside Space
Strong Buy
Buy
Hold
Sell
Strong Sell

Peer Comparison

93
Total
4
Median
7
Average
Company name
Ratings
Analysts
Movano Inc
MOVE
1
Boston Scientific Corp
BSX
37
Edwards Lifesciences Corp
EW
35
Intuitive Surgical Inc
ISRG
35
Veeva Systems Inc
VEEV
30
Thermo Fisher Scientific Inc
TMO
30
1
2
3
...
19

Financial Forecasting

EPS
Revenue
Net Profit
EBIT
Relevant data have not been disclosed by the company yet.

Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.

Price Momentum

Currency: USD Updated: 2026-05-15

The current price momentum score of Movano Inc is 9.24, ranking 13 out of 206 in the Healthcare Equipment & Supplies industry. Currently, the stock price is trading between the resistance level at 23.76 and the support level at 14.21, making it suitable for range-bound swing trading.

Score

Industry at a Glance

Previous score
9.40
Change
-0.16

Support & Resistance

Relevant data have not been disclosed by the company yet.

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

Indicators
Sell(2)
Neutral(1)
Buy(4)
Indicators
Value
Direction
MACD(12,26,9)
0.814
Buy
RSI(14)
66.242
Neutral
STOCH(KDJ)(9,3,3)
78.455
Buy
ATR(14)
1.843
High Vlolatility
CCI(14)
153.657
Buy
Williams %R
21.261
Buy
TRIX(12,20)
0.827
Sell
StochRSI(14)
77.583
Sell
Moving Average
Sell(0)
Neutral(0)
Buy(6)
Indicators
Value
Direction
MA5
17.838
Buy
MA10
15.747
Buy
MA20
16.203
Buy
MA50
13.220
Buy
MA100
10.738
Buy
MA200
8.164
Buy

Institutional Confidence

Currency: USD Updated: 2026-05-15

The current institutional shareholding score of Movano Inc is 3.00, ranking 133 out of 206 in the Healthcare Equipment & Supplies industry. The latest institutional shareholding proportion is 5.49%, representing a quarter-over-quarter decrease of 39.98%. The largest institutional shareholder is Mairs and Power, holding a total of 50.97K shares, representing 2.57% of shares outstanding, with 51.77% decrease in holdings.

Score

Industry at a Glance

Previous score
3.00
Change
0

Institutional Shareholding

Relevant data have not been disclosed by the company yet.

Shareholder Activity

Name
Shares Held
Chg %
Cogan (Jeremy D.)
101.86K
+57.04%
Appel (Peter A)
64.88K
--
Mastrototaro (John)
56.11K
+2786.52%
Mairs and Power, Inc.
Star Investors
37.53K
-0.00%
Leabman Holdings LLC
37.53K
--
Fairbairn (Malcolm P.)
33.23K
--
Fairbairn Emily Wang
16.64K
+167.88%
Raymond James & Associates, Inc.
16.50K
--
Wirk (Shaheen)
15.96K
+167.79%
Cullinan (Brian)
9.62K
+413.45%
1
2

Risk Assessment

Currency: USD Updated: 2026-05-15

The U.S. Dollar Index is currently in a neutral state, which has a neutral effect on the Healthcare Equipment & Supplies domestic-focused industry. The Dollar Index (DXY) measures the value of the U.S. dollar against a basket of major currencies, including the euro, yen, pound sterling, Canadian dollar, Swedish krona, and Swiss franc. The current risk assessment score of Movano Inc is 1.04, ranking 198 out of 206 in the Healthcare Equipment & Supplies industry. The company's beta value is 1.18. This indicates that the stock tends to outperform the index during upward trending markets but experiences larger declines during downward trending markets. with an industry-leading ESG disclosure.

Score

Industry at a Glance

Previous score
1.04
Change
0
Beta vs S&P 500 index
1.22
VaR
+9.94%
240-Day Maximum Drawdown
+55.83%
240-Day Volatility
+234.15%

Return

Best Daily Return
60 days
+59.31%
120 days
+140.17%
5 years
+149.69%
Worst Daily Return
60 days
-15.32%
120 days
-15.32%
5 years
-25.47%
Sharpe Ratio
60 days
+2.76
120 days
+1.66
5 years
+0.08

Risk Assessment

Maximum Drawdown
240 days
+55.83%
3 years
+97.88%
5 years
+99.29%
Return-to-Drawdown Ratio
240 days
+5.82
3 years
-0.29
5 years
-0.19
Skewness
240 days
+6.09
3 years
+7.29
5 years
+7.71

Volatility

Realised Volatility
240 days
+234.15%
5 years
+149.29%
Standardised True Range
240 days
+5.69%
5 years
+56.14%
Downside Risk-Adjusted Return
120 days
+636.38%
240 days
+636.38%
Maximum Daily Upside Volatility
60 days
+178.95%
Maximum Daily Downside Volatility
60 days
+91.04%

Liquidity

Average Turnover Rate
60 days
+0.83%
120 days
+7.34%
5 years
--
Turnover Deviation
20 days
-94.54%
60 days
-93.51%
120 days
-42.44%

Peer Comparison

Healthcare Equipment & Supplies
Movano Inc
Movano Inc
MOVE
4.67 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Lantheus Holdings Inc
Lantheus Holdings Inc
LNTH
8.68 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Anika Therapeutics Inc
Anika Therapeutics Inc
ANIK
8.58 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
LivaNova PLC
LivaNova PLC
LIVN
8.37 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Thermo Fisher Scientific Inc
Thermo Fisher Scientific Inc
TMO
8.35 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
Bruker Corp
Bruker Corp
BRKR
8.23 /10
Score
Financial Health
Valuation Dimensions
Earnings Forecast
Price Momentum
Institutional Confidence
Risk Assessment
View more
KeyAI